IntrinsicIntrinsic
← All summaries

Above Food Ingredients Inc.

ABVEW
Financials & Chart →

Business Summary

Above Food Ingredients Inc. (New Above Food or the Company) operates as an Alberta-based innovative food company that leverages a vertically integrated supply chain to deliver differentiated ingredients and consumer products, with a vision to create a healthier world through chain of custody plant proteins, traceability, quantifiable sustainability, and nutrient density . The Company's business model is centered on generating revenue through two reportable segments: Disruptive Agriculture and Rudimentary Ingredients, and Consumer Packaged Goods (CPG) . The Disruptive Agriculture and Rudimentary Ingredients segment focuses on the provisioning of discrete genetics, origination, purchasing, grading, primary processing, and sale of regeneratively grown grain, as well as the origination, purchase, and sale of bespoke ingredients products, processed primarily through Company-owned ingredient facilities . The CPG segment formulates, manufactures, sells, distributes, and markets proprietary consumer product formulations in owned brands and also focuses on manufacturing and distribution for private-labeled retail owned brands . A significant percentage of the Disruptive Agriculture and Rudimentary Ingredients revenue is contracted over 3 to 12 months with customers, with terms allowing for cancellation upon events of force majeure .

For the fiscal year ended January 31, 2024 (FY24), the Company reported total revenue of $368,423,398 , a decrease of 7.1% from $396,464,504 in the fiscal year ended January 31, 2023 (FY23) . Cost of sales for FY24 was $374,322,146 , resulting in a gross loss of $5,898,748 , which represents a 361.0% increase in gross loss compared to the $1,279,640 gross loss in FY23 . Operating loss for FY24 was $42,099,461 , an increase of 6.1% from $39,683,831 in FY23 . The net loss for FY24 was $53,312,282 , an increase of 17.2% from the $45,484,530 net loss in FY23 . Diluted EPS for FY24 was $(0.69) , compared to $(0.60) in FY23 . As of January 31, 2024, cash and cash equivalents stood at $952,280 , and the Company had a working capital deficiency of $85,414,272 . Total liabilities were $190,146,187 , with long-term debt (including current portion) of $30,969,307 .

Revenue for the Disruptive Agriculture and Rudimentary Ingredients segment decreased to $356,400,000 in FY24 from $387,000,000 in FY23 . This decrease was primarily attributed to working capital constraints that capped growth, as well as price decreases in durum, peas, wheat, canary seed, and canola, which offset a significant increase in durum volumes . The average price of durum in FY24 was $482.92 per metric ton, compared to $529.98 for FY23 . Conversely, CPG revenues increased to $11,600,000 in FY24 from $9,400,000 in FY23 , largely due to acquisitions that closed in May and June 2022 being included for the full FY24, compared to partial inclusion in FY23 . The gross loss increased in FY24 due to inventory impairment and write-offs of approximately $3.0 million, including a $2.7 million write-off of oat inventory due to the discontinuance of the oat grower program and a $285,000 write-down of CPG inventory . Selling, general, and administrative (SG&A) expenses increased by $3.1 million, or 10.0%, to $34,222,524 in FY24 from $31,107,404 in FY23 , driven by increased professional fees of $3.5 million related to the go-public process and increased rent of $1.4 million due to operating leases and consolidation of acquired operations . Interest expense increased by $2.3 million to $7,670,156 in FY24 from $5,378,560 in FY23 , primarily due to new credit facilities and increased interest rates on variable rate facilities . The equity method investment loss increased by $3.0 million to $3,787,927 in FY24 from $812,669 in FY23 , mainly due to a $3.3 million impairment of the investment in ANF .

During FY24, the Company completed the acquisition of Discovery Seed Labs Ltd. (DSL) on March 23, 2023, for $3,213,563, paid with $2 million cash and 502,088 class A common shares valued at $1,213,563 . This acquisition added a seed testing and genomics laboratory to the Company's operations . In June 2024, the Company acquired the remaining 66.94% interest in ANF for 1,604,253 New Above Food Common Shares, making ANF a wholly owned subsidiary . The Company also entered into an asset purchase agreement on May 14, 2024, with Arcadia Biosciences, Inc. and Arcadia Wellness, LLC, to purchase assets including inventory and intellectual property, in exchange for a $6,000,000 USD promissory note . Additionally, on June 13, 2024, Above issued 2,377,082 common shares for cash proceeds of $5 million USD to Grupo Empresarial Enhol, S.L., and concurrently issued 6,180,413 common shares to Enhol as consideration for 100% of Brotalia, S.L. .

Business Outlook

A key component of Above Food's growth strategy is organic or internal growth, aiming for profitable and sustainable revenue growth through the sale of existing higher margin products, expansion into new channels, attracting new customers, introducing higher margin products, building strategic partnerships, and investing in continuous improvement in plants and organization to improve efficiencies and simplify the business . The Company also plans for growth through acquisitions and securing long-term contracts . A significant percentage of the Disruptive Agriculture and Rudimentary Ingredients revenue is contracted over 3 to 12 months with customers, which management believes will result in stable revenues over time, despite experienced fluctuations .

The Company expects to reduce its relative Research & Development (R&D) cost significantly in the near term as it works to commercialize existing intellectual property . Management believes the refinement of current operations and intellectual property is crucial to long-term growth and strategy .

The Company expects to incur additional annual expenses related to being a publicly listed company, including directors' and officers' liability insurance, director fees, SEC reporting requirements, transfer agent fees, hiring additional accounting, legal and administrative personnel, increased auditing and legal fees, and similar expenses . Management believes that the proceeds from the Business Combination, together with current available funds, will provide sufficient liquidity to fully fund future operations and any potential planned expansion of the business . The Company also intends to expand its existing credit facility to accommodate business growth and provide additional liquidity, which is dependent on additional financing being raised . If unsuccessful in expanding the credit facility, the Company may be forced to reduce operations and idle certain assets .

The Company has identified and begun to realize a number of synergies from acquired operations, resulting from restructuring of management teams, sharing resources, brand consolidation, and leveraging its robust supply chain in product formulations . The Company expects supply chain challenges, including higher raw material costs, higher freight and logistics costs, and disruptions from labor shortages and ingredient availability, to continue in the 2025 fiscal year . Management believes that instituted price increases and additional cost savings initiatives will enable continued investment in growth projects .

The Company plans to continue to be active in R&D as it invests in growing intellectual property, product offerings, and expanding market reach . Planned capital allocation includes R&D spending, though a reduction in relative R&D cost is expected in the near term as existing intellectual property is commercialized . The Company's main sources of liquidity are its operations, equity issuances, and debt issuances, with funds primarily used to finance working capital and capital expenditure requirements . The Company believes these sources will be sufficient to finance continued operations, growth strategy, and additional expenses for at least the next twelve months . The Company may issue debt and/or equity securities on an opportunistic basis, dependent upon market conditions and available pricing .

Risk Factors

The Company faces several material risks, including recurring losses from operations, a working capital deficiency of $85,414,272 as of January 31, 2024 , and violations of restrictive covenants related to approximately $66 million of its aggregate borrowings as of January 31, 2024 . There is no assurance that the Company will be successful in obtaining further equity and debt financing or maintaining the support of current lenders, particularly concerning indebtedness in default . The Company also expects to incur recurring losses as it grows and has incurred significant costs in preparation for its public transaction . Climate change presents long-term challenges, including increasing expectations for climate actions and reductions of GHG emissions, and physical risks such as more intense weather events, longer droughts, rising sea levels, and changes in temperature and precipitation patterns, which can impact operations, customers, and the supply chain . Global decarbonization ambitions and energy transition are driving carbon regulations and informing investor capital allocation priorities, exposing Above Food to evolving risks related to potential regulatory changes, including carbon pricing . The impact of climate changes on customer operations is uncertain and may be negative, and climate change laws could increase costs and impact financial condition . Logistics bottlenecks from poor highway conditions or adverse weather may delay product delivery and impact financial results . The Company is exposed to currency risk from US dollar denominated sales and expenses, and commodity price risk due to volatility in agricultural commodity prices, which can affect comprehensive income and operating cash flows if not properly managed . A 1% increase in interest rates would increase interest expense for FY24 by approximately $1.0 million .

Management Priorities

Management's message to shareholders emphasizes a growth strategy focused on organic or internal growth, aiming to deliver profitable and sustainable revenue growth through the sale of existing higher margin products, expanding into new channels, attracting new customers, introducing higher margin products, building strategic partnerships through consumer and customer insights, and investing in continuous improvement in plants and organization to improve efficiencies and simplify the business . Management also highlights growth through acquisitions and securing long-term contracts as strategic priorities . The Company expects to incur additional annual expenses related to being a publicly listed company . Management believes that the proceeds from the Business Combination, together with current available funds, will provide sufficient liquidity to fully fund future operations and any potential planned expansion of the business . The Company intends to expand its existing credit facility to accommodate business growth and provide additional liquidity . Management also explicitly states the intention to reduce relative R&D cost significantly in the near term as the Company works to commercialize existing intellectual property, recognizing the value in continuing as a leader in regenerative agriculture and the crucial role of current operations and intellectual property refinement for long-term growth and strategy .

View Source Annual Report on SEC.gov ↗

References

  1. [1] Item 5, Operating and Financial Review and Prospects — Company Overview
  2. [2] Item 5, Operating and Financial Review and Prospects — Company Overview
  3. [3] Item 5, Operating and Financial Review and Prospects — Company Overview
  4. [4] Item 5, Operating and Financial Review and Prospects — Company Overview
  5. [5] Item 5, Operating and Financial Review and Prospects — Growth Strategy and Outlook
  6. [6] Item 5, Operating and Financial Review and Prospects — Results of Operations
  7. [7] Item 5, Operating and Financial Review and Prospects — Results of Operations
  8. [8] Item 5, Operating and Financial Review and Prospects — Results of Operations
  9. [9] Item 5, Operating and Financial Review and Prospects — Results of Operations
  10. [10] Item 5, Operating and Financial Review and Prospects — Results of Operations
  11. [11] Item 5, Operating and Financial Review and Prospects — Results of Operations
  12. [12] Item 5, Operating and Financial Review and Prospects — Results of Operations
  13. [13] Item 5, Operating and Financial Review and Prospects — Results of Operations
  14. [14] Item 5, Operating and Financial Review and Prospects — Results of Operations
  15. [15] Item 8, Financial Information — Consolidated Statements of Operations and Comprehensive Loss
  16. [16] Item 8, Financial Information — Consolidated Statements of Operations and Comprehensive Loss
  17. [17] Item 8, Financial Information — Consolidated Balance Sheets
  18. [18] Item 5, Operating and Financial Review and Prospects — Liquidity and capital resources
  19. [19] Item 8, Financial Information — Consolidated Balance Sheets
  20. [20] Item 8, Financial Information — Consolidated Balance Sheets
  21. [21] Item 5, Operating and Financial Review and Prospects — Company Overview
  22. [22] Item 5, Operating and Financial Review and Prospects — Revenue
  23. [23] Item 5, Operating and Financial Review and Prospects — Revenue
  24. [24] Item 5, Operating and Financial Review and Prospects — Company Overview
  25. [25] Item 5, Operating and Financial Review and Prospects — Company Overview
  26. [26] Item 5, Operating and Financial Review and Prospects — Gross profit (loss)
  27. [27] Item 5, Operating and Financial Review and Prospects — Selling, general, and administrative (“SG&A”) expenses
  28. [28] Item 5, Operating and Financial Review and Prospects — Selling, general, and administrative (“SG&A”) expenses
  29. [29] Item 5, Operating and Financial Review and Prospects — Interest expense
  30. [30] Item 5, Operating and Financial Review and Prospects — Interest expense
  31. [31] Item 5, Operating and Financial Review and Prospects — Equity method investment loss
  32. [32] Item 5, Operating and Financial Review and Prospects — Equity method investment loss
  33. [33] Item 5, Operating and Financial Review and Prospects — Acquisitions
  34. [34] Item 5, Operating and Financial Review and Prospects — Acquisitions
  35. [35] Item 5, Operating and Financial Review and Prospects — Acquisitions
  36. [36] Item 10, Additional Information — Material Contracts
  37. [37] Item 10, Additional Information — Material Contracts
  38. [38] Item 5, Operating and Financial Review and Prospects — Growth Strategy and Outlook
  39. [39] Item 5, Operating and Financial Review and Prospects — Growth Strategy and Outlook
  40. [40] Item 5, Operating and Financial Review and Prospects — Growth Strategy and Outlook
  41. [41] Item 5, Operating and Financial Review and Prospects — Research and Development
  42. [42] Item 5, Operating and Financial Review and Prospects — Research and Development
  43. [43] Item 5, Operating and Financial Review and Prospects — The Business Combination and Public Company Costs
  44. [44] Item 5, Operating and Financial Review and Prospects — Liquidity and capital resources
  45. [45] Item 5, Operating and Financial Review and Prospects — Liquidity and capital resources
  46. [46] Item 5, Operating and Financial Review and Prospects — Liquidity and capital resources
  47. [47] Item 5, Operating and Financial Review and Prospects — Selling, general, and administrative (“SG&A”) expenses
  48. [48] Item 5, Operating and Financial Review and Prospects — Business Trends
  49. [49] Item 5, Operating and Financial Review and Prospects — Business Trends
  50. [50] Item 5, Operating and Financial Review and Prospects — Research and Development
  51. [51] Item 5, Operating and Financial Review and Prospects — Research and Development
  52. [52] Item 5, Operating and Financial Review and Prospects — Liquidity and capital resources
  53. [53] Item 5, Operating and Financial Review and Prospects — Liquidity and capital resources
  54. [54] Item 5, Operating and Financial Review and Prospects — Liquidity and capital resources
  55. [55] Item 5, Operating and Financial Review and Prospects — Liquidity and capital resources
  56. [56] Item 5, Operating and Financial Review and Prospects — Liquidity and capital resources
  57. [57] Item 5, Operating and Financial Review and Prospects — Liquidity and capital resources
  58. [58] Item 5, Operating and Financial Review and Prospects — Liquidity and capital resources
  59. [59] Item 5, Operating and Financial Review and Prospects — Business Trends
  60. [60] Item 5, Operating and Financial Review and Prospects — Business Trends
  61. [61] Item 5, Operating and Financial Review and Prospects — Business Trends
  62. [62] Item 5, Operating and Financial Review and Prospects — Business Trends
  63. [63] Item 11, Quantitative and Qualitative Disclosures About Market Risk — Foreign currency risk.
  64. [64] Item 2, Summary of Significant Accounting Policies — Interest rate risk
  65. [65] Item 5, Operating and Financial Review and Prospects — Growth Strategy and Outlook
  66. [66] Item 5, Operating and Financial Review and Prospects — Growth Strategy and Outlook
  67. [67] Item 5, Operating and Financial Review and Prospects — The Business Combination and Public Company Costs
  68. [68] Item 5, Operating and Financial Review and Prospects — Liquidity and capital resources
  69. [69] Item 5, Operating and Financial Review and Prospects — Liquidity and capital resources
  70. [70] Item 5, Operating and Financial Review and Prospects — Research and Development

Analysis on 5/22/2026